HQH vs HQL

Tekla Healthcare Investors vs TeklaLife Sciences Investors — Valuation Comparison 2026

HQH

Asset Management
Tekla Healthcare Investors
Quality
1.8
out of 10
Value Trap
Price
$19.65
Last close
Models
9/13
Active
VS

HQL

Asset Management
TeklaLife Sciences Investors
Quality
1.9
out of 10
Value Trap
Price
$17.67
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType HQH Fair ValueHQH Upside HQL Fair ValueHQL Upside
Bayesian DCF Intrinsic $5.20 -73.5% $4.68 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $22.03 +12.1% $71.50 +307.4%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HQH vs HQL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HQH vs HQL — Which Stock Is More Undervalued?

HQL scores higher with a 1.9/10 quality rating vs HQH's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tekla Healthcare Investors (HQH) and TeklaLife Sciences Investors (HQL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HQH currently trades at $19.65 with a QOC of 1.8/10, while HQL trades at $17.67 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).